Endocrinology Grand Rounds
3/12/2013 8:00 AM - 9:00 AM
Harold Hamm Diabetes Center, 2900
Tyrosine Kinase Inhibitors and Thyroid Cancer
Madona Azar, MD, Assistant Professor, Department of Medicine/Endocrinology and Diabetes
Objectives: Upon completion of this activity, participants will be able to: Understand the current role of tyrosine kinases inhibitors in advanced or progressive thyroid cancer and recognize available agents.
For more information contact:
Department of Medicine/Endocrinology and Diabetes